MS-10 (300mg)

Natural health product licensed in Canada

Other names: Medmeno 300
Licence holder: Barentz Canada ULC
NPN or DIN-HM: 80121629
Status: Active licence
Licence date: 21 October 2022
Revision date: 6 July 2026
Form: Capsule
Route of administration: Orale
Application type: Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Maltodextrine, Hypromellose, Phosphate dicalcique, Stéarate de magnésium, Cellulose microcristalline, Silice

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	minimum: 18 years	1 Capsule	1 day

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to reduce symptoms of menopause such as facial flushing, night sweats, sleep disturbances and nervousness. Clinically shown to help relieve symptoms of menopause such as facial flushing, night sweats, sleep disturbances and nervousness. Helps promote/maintain/support sexual health in menopausal women. Clinically shown to help promote/maintain/support sexual health in menopausal women. Helps support healthy mood balance during menopause. Helps support emotional aspects of sexual health in women. Helps to reduce cortisol levels, a biomarker of physical stress. Helps to reduce cortisol levels in the blood, a leading indicator of stress. Clinically shown to help reduce menopausal symptoms including hot flashes, night sweats, low energy, difficulty sleeping, difficulty concentrating, irritability/nervousness, muscle and joints discomfort, headaches, paresthesia (tingling, burning sensation of the skin), vertigo and vaginal dryness MS-10 helps to provide menopausal symptom relief.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.